Total Clarity Wealth Management, Inc. X4 Pharmaceuticals, Inc Transaction History

Total Clarity Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$0.72 - $1.46 $9,850 - $19,974	13,681 New	13,681 $19,000
Q3 2023 Oct 24, 2023	SELL	$1.03 - $2.02 $138,018 - $270,677	-133,999 Reduced 92.08%	11,532 $12,000
Q2 2023 Jul 24, 2023	BUY	$0.82 - $2.49 $110,315 - $334,982	134,531 Added 1223.01%	145,531 $282,000
Q1 2023 May 04, 2023	BUY	$0.8 - $1.22 $8,800 - $13,420	11,000 New	11,000 $9,000

105

100M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $23.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.